2023-02495. National Cancer Institute; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Institute Council of Research Advocates.

    The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend as well as those who need special assistance, such as sign language interpretation or other reasonable accommodations, Start Printed Page 7988 should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website ( http://videocast.nih.gov).

    Name of Committee: National Cancer Institute Council of Research Advocates.

    Date: March 1, 2023.

    Time: 10:00 a.m. to 4:00 p.m.

    Agenda: Welcome and Chairwoman's Remarks, NCI Director's Update, NCI Updates and Legislative Update.

    Place: Porter Neuroscience Research Center, Building 35A, Room 610, 35 Convent Drive, Bethesda, MD 20892.

    Contact Person: Amy Williams, Acting Director, NCI Office of Advocacy Relations National Cancer Institute, NIH, 9000 Rockville Pike, Building 31, Room 10A28, Bethesda, MD 20892, (240) 781-3406, williaam@mail.nih.gov.

    Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

    In the interest of security, NIH has procedures at https://www.nih.gov/​about-nih/​visitor-information/​campus-access-security for entrance into on-campus and off-campus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.

    Additional Health and Safety Guidance: Before attending a meeting at an NIH facility, it is important that visitors review the NIH COVID-19 Safety Plan at https://ors.od.nih.gov/​sr/​dohs/​safety/​NIH-covid-19-safety-plan/​Pages/​default.aspx for information about requirements and procedures for entering NIH facilities, especially when COVID-19 community levels are medium or high. In addition, the Safer Federal Workforce website has FAQs for visitors at https://www.saferfederalworkforce.gov/​faq/​visitors/​. Please note that if an individual has a COVID-19 diagnosis within 10 days of the meeting, that person must attend virtually. (For more information please read NIH's Requirements for Persons after Exposure at https://ors.od.nih.gov/​sr/​dohs/​safety/​NIH-covid-19-safety-plan/​COVID-assessment-testing/​Pages/​persons-after-exposure.aspx and What Happens When Someone Tests Positive at https://ors.od.nih.gov/​sr/​dohs/​safety/​NIH-covid-19-safety-plan/​COVID-assessment-testing/​Pages/​test-positive.aspx.) Anyone from the public can attend the open portion of the meeting virtually via the NIH Videocasting website ( http://videocast.nih.gov). Please continue checking these websites, in addition to the committee website listed below, for the most up to date guidance as the meeting date approaches.

    Information is also available on the Institute's/Center's home page: NCRA: http://deainfo.nci.nih.gov/​advisory/​ncra/​ncra.htm, where an agenda and any additional information for the meeting will be posted when available.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

    Start Signature

    Dated: February 1, 2023.

    Melanie J. Pantoja,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2023-02495 Filed 2-6-23; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
02/07/2023
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2023-02495
Dates:
March 1, 2023.
Pages:
7987-7988 (2 pages)
PDF File:
2023-02495.pdf